CMS BALANCE Model Oral GLP-1: Which Pills Are Covered, and How to Get Them in 2026

The 30-second verdict

First, the honest part nobody puts up top

Here’s our one big “buyer beware” for this whole topic: the name “BALANCE Model” is misleading for 2026. The BALANCE Model is the big, long-term government plan to cover GLP-1 drugs. But the thing actually putting a pill in a Medicare patient’s hands this year is the Medicare GLP-1 Bridge — a shorter, simpler program built to “bridge” the gap until the bigger one is ready. And there’s a twist: the BALANCE Model is not launching for Medicare drug plans (Part D) in 2027. Not enough drug plans signed up voluntarily by the CMS deadline. So for Medicare, the Bridge is the only active path in 2026–2027.

We know — that’s annoying. You came here for a clean answer and got two program names and a delay.

But that’s exactly why this page exists. Once you stop asking “is it BALANCE or the Bridge?” and start asking “which lane am I in?”, this gets simple fast. We’ll separate the lanes for you below, drug by drug, so you don’t make a coverage decision off a headline. No pitch. Just the map.

CMS BALANCE Model oral GLP-1: does it cover the pills?

Yes. The BALANCE Model’s drug list includes oral pills — Foundayo, Rybelsus, and the tablet form of Wegovy — alongside the GLP-1 shots. But being on the BALANCE list is not the same as getting the $50 Medicare price right now. For Medicare in 2026 and 2027, the $50 deal flows through the Medicare GLP-1 Bridge, which covers a shorter list: Foundayo, Wegovy (shot and pill), and the Zepbound KwikPen.

Here’s the simple version:

• ✓Foundayo (a pill): Yes — one of the two oral pills that matter for the $50 Medicare price.
• ✓Wegovy pill (a pill): Yes — the other oral pill that matters for the $50 price.
• ✗Rybelsus (a pill): It’s on the bigger BALANCE list, but not on the $50 Bridge weight-loss list. (More on why below — this trips up a lot of people.)
• ✗Compounded “oral semaglutide” sold online: No. These products aren’t part of any CMS program.

The full BALANCE drug list, agreed to by drugmakers Novo Nordisk and Eli Lilly, is: all forms of Foundayo, Mounjaro, Ozempic, Rybelsus, and Wegovy, plus the Zepbound KwikPen.

The CMS Oral GLP-1 Coverage Lane Map (our 2026 matrix)

To build this table, we cross-checked the CMS BALANCE page, three separate CMS Bridge pages, and each drug’s FDA approval. Find your drug, then look at whether it qualifies for the $50 Bridge price for weight loss.

Sources: CMS BALANCE Model; CMS Medicare GLP-1 Bridge — Beneficiaries, Providers, and Part D Plans; KFF. This table is coverage routing, not medical advice. What you actually get depends on your plan type, your diagnosis, your BMI history, your doctor’s paperwork, and (for Medicaid) your state.

Which oral GLP-1 pills can get the $50 Medicare price?

Two: the Wegovy pill and Foundayo. The Medicare GLP-1 Bridge lists Foundayo (all doses), Wegovy (shot and tablet), and the Zepbound KwikPen as the weight-loss drugs eligible for the flat $50 monthly price. Of those, the pills are Foundayo and the Wegovy tablet.

Both are real, FDA-approved pills. Neither is a compounded product. Here’s how they actually differ day-to-day — which matters more than the price, since the price is the same $50 if you qualify.

Sources: Novo Nordisk (Wegovy pill FDA approval); Eli Lilly (Foundayo FDA approval); Ro (oral GLP-1 guide). Trial weight-loss numbers come from two separate studies, not a head-to-head comparison. Designs and patient populations differed.

Quick read: if you hate fussy timing rules, Foundayo’s “any time, with or without food” is a real perk. If trial weight-loss numbers are what you’re weighing, Wegovy posted the higher figure in its own study. But this is your doctor’s call, not ours — both are treated as Bridge drugs if you qualify, and your health history decides what’s safe and right for you.

For a deeper side-by-side, see our Wegovy pill vs. Foundayo comparison.

Is Rybelsus covered by the $50 Medicare program?

No — not by the $50 Medicare GLP-1 Bridge. Rybelsus is an oral GLP-1, and it is on the broader BALANCE drug list. But the Bridge’s $50 weight-loss list names Foundayo, Wegovy, and the Zepbound KwikPen — not Rybelsus. That’s because Rybelsus is FDA-approved for type 2 diabetes, not weight loss.

This is the single biggest mix-up we see. People think “Rybelsus is a pill, and pills are in the program, so I get it for $50.” Not quite. If your Rybelsus is for diabetes, it most likely runs through your regular Part D plan — which has its own copay, and sometimes that copay is lower than $50, especially if you get Extra Help. Don’t switch lanes without checking.

See also: Foundayo vs. Rybelsus — full comparison

What if your GLP-1 is for diabetes, heart-risk, sleep apnea, or MASH?

If your GLP-1 is prescribed for a use Medicare Part D already covers — type 2 diabetes, heart-risk reduction with Wegovy, sleep apnea with Zepbound, or the liver condition MASH — it runs through your regular Part D plan, not the $50 Bridge. CMS is clear that the Bridge is only for weight-loss use, and only for people who don’t have those covered conditions.

In plain terms: the Bridge isn’t a cheaper side door for a drug your plan would already cover for a medical condition. If you have one of those diagnoses, CMS says you should keep getting your GLP-1 through your Part D plan. Your doctor actually has to confirm on the Bridge form that you don’t have type 2 diabetes, sleep apnea, or MASH before the weight-loss path opens.

So don’t ask your doctor to “send it to the Bridge” if it’s really a diabetes or heart prescription. The right move is to compare your regular Part D copay against the $50 — sometimes your plan wins, especially with Extra Help.

Who qualifies for the $50 Bridge price?

Qualifying isn’t about wanting a pill — it’s about meeting CMS’s rules. You must be in a Medicare Part D drug plan, the pill must be for weight management, and your doctor must confirm you meet one of three BMI-and-health checkpoints. Your doctor files the paperwork; you don’t sign up yourself.

There are two gates. You need to pass both.

The catch: $50 isn’t always your cheapest lane

Here’s the part the “$50 GLP-1!” headlines skip: the Bridge sits outside your normal Part D plan. So the $50 you pay does not count toward the roughly $2,000 yearly cap on what you spend on Part D drugs, and Extra Help (the low-income subsidy) does not lower it. For some people that’s no big deal. For others, regular Part D coverage ends up cheaper overall.

Translation: the Bridge gives you a clean $50 a month, but those dollars are invisible to your plan’s safety net. If you already hit your Part D cap because of other prescriptions, or you get Extra Help, your “regular” copay might beat $50.

There’s no rush and no trick. The Bridge runs through December 31, 2027, and what happens after that depends on future CMS decisions. Take the time to compare. See our guide Medicare GLP-1 Bridge: what the $50 copay really means.

What changes if you have Medicaid instead of Medicare?

Medicaid is its own lane, and it’s state-by-state. The BALANCE Model lets state Medicaid programs offer covered GLP-1s, but each state chooses whether and when to join. States can begin joining in May 2026, and the Medicaid part of the model runs through December 2031.

• ▸If your state joined BALANCE: access may open up under standard rules and prices the state agreed to with the drugmakers.
• ▸If your state hasn’t joined: your state’s existing Medicaid drug rules still apply. As of January 2026, KFF reported that 13 states covered GLP-1s for weight loss at all.
• ▸If your pill is for diabetes: Medicaid may already cover it under normal rules — separate from the weight-loss question.

For the latest state-by-state picture, see our GLP-1 providers that accept Medicaid.

What if you don’t qualify — or you’re not on Medicare yet?

You can still get the same FDA-approved pills privately — if a licensed clinician prescribes them. If you don’t meet the Bridge rules, you’re in a plan type that’s left out, or you’re not on Medicare yet, the Wegovy pill and Foundayo are both sold to cash-pay patients — and a telehealth provider can run a free check to see if your job or marketplace insurance helps.

If no — you’re not on Medicare, you didn’t meet the rules, or your plan type is left out — then this is your path.

Are compounded “oral semaglutide” pills part of this program?

No. CMS covers specific brand-name, FDA-approved products. Compounded GLP-1 products — the cheaper “semaglutide” or “tirzepatide” versions some websites sell — are not FDA-approved finished drugs, and there is no confirmed CMS coverage path for them. Don’t treat a compounded pill as the same thing as Foundayo, the Wegovy pill, or Rybelsus when you’re thinking about Medicare or Medicaid.

We mention this because the phrase “oral GLP-1” gets used loosely online, and it’s easy to land on a compounded offer thinking it’s the program you read about. It isn’t. For this Medicare and Medicaid topic, stick to the named FDA-approved pills.

Oral GLP-1 safety, in plain language

These pills can cause real side effects, and they’re not for everyone. The most common problems are stomach-related: nausea, vomiting, and diarrhea, especially as the dose goes up. Both Foundayo and the Wegovy pill carry the strongest type of FDA warning (a “boxed warning”) about a rare thyroid tumor risk seen in animal studies.

• ▸Thyroid history: Foundayo, the Wegovy pill, Rybelsus, and the Ozempic pill all carry the same warning — they should not be used if you or a family member has had a type of thyroid cancer called MTC, or a condition called MEN2.
• ▸Pregnancy: these aren’t for use in pregnancy. Foundayo’s label also notes that people on birth-control pills may need to add a backup method for a stretch after starting and after each dose increase, because the pill can affect how the body absorbs other medicines.
• ▸Other medicines: if you take diabetes drugs like insulin, your doses may need adjusting.

This page explains coverage, not treatment. Whether a GLP-1 is safe and right for you is a conversation for you and a licensed clinician.

How to get ready for July 1, 2026

You can’t file a Bridge request before July 1, 2026 — but you can get everything lined up now so you’re ready the moment it opens. CMS has already released materials for prescribers and pharmacies, plus a prior-authorization form, though requests still won’t be accepted before launch day.

1. 1Confirm your plan type. Standalone Part D, MA-PD, SNP, EGWP, or LI NET? (Your insurance card or plan documents say.)
2. 2Pin down the exact pill. Foundayo or the Wegovy pill, and the dose.
3. 3Be clear on the reason. Weight loss runs through the Bridge; diabetes, heart-risk, sleep apnea, or MASH run through regular Part D.
4. 4Get your starting BMI on record. Remember, it's the BMI from when you began treatment.
5. 5Ask which lane fits. Bridge, regular Part D, Medicaid, or cash.

What we actually verified

We built this page from primary sources, and we want you to be able to check our work.

What we did not verify (check for yourself): whether you personally qualify; your specific plan’s decision; your state’s Medicaid status; whether a specific pharmacy can fill it; and any details CMS may update before launch. We re-check this page monthly while the program rolls out.

Frequently asked questions

Is the CMS BALANCE Model the same as the Medicare GLP-1 Bridge?

No. BALANCE is the larger, longer-term program; the Medicare GLP-1 Bridge is the short-term path giving eligible Medicare members $50/month access from July 1, 2026 through December 31, 2027. For Medicare weight-loss use in 2026–2027, the Bridge is the program that applies.

Does the CMS BALANCE Model cover oral GLP-1 pills?

Yes. The BALANCE drug list includes the pills Foundayo, Rybelsus, and the Wegovy tablet, along with several injectables. But the $50 Medicare Bridge list is narrower, so the Bridge list should be checked separately.

Which oral GLP-1 pills can I get for $50 through Medicare?

Foundayo and the Wegovy pill. Both are FDA-approved weight-loss pills on the Medicare GLP-1 Bridge list when used for weight management and when eligibility rules are met.

Is Rybelsus covered by the Medicare GLP-1 Bridge?

No. Rybelsus is on the broader BALANCE list, but it is not on the $50 Bridge weight-loss list. Rybelsus is approved for type 2 diabetes, so it usually runs through regular Part D.

Is the Ozempic pill covered for weight loss?

No. The Ozempic pill (oral semaglutide, approved January 2026) is approved for type 2 diabetes, not weight loss, and it is not on the $50 Medicare GLP-1 Bridge list.

Does the $50 Bridge copay count toward my Part D out-of-pocket cap?

No. The Bridge operates outside the Part D benefit, so the $50 does not count toward the roughly $2,000 yearly Part D out-of-pocket cap, and the Low-Income Subsidy (Extra Help) does not lower it.

Can my doctor file the Bridge request before July 1, 2026?

No. CMS will not accept Medicare GLP-1 Bridge prior-authorization requests before July 1, 2026. Patients can prepare their information beforehand.

Does Medicaid cover oral GLP-1s through the BALANCE Model?

It depends on the state. States can join the BALANCE Model on a rolling basis starting around May 2026, and each state sets its own timing and coverage rules.

Are compounded oral semaglutide pills part of CMS BALANCE?

No. CMS covers specific brand-name FDA-approved products. Compounded oral GLP-1 products are not FDA-approved finished drugs and have no confirmed CMS coverage path.

What if I don't qualify for Medicare or Medicaid coverage?

The same FDA-approved pills can be accessed cash-pay if a clinician prescribes them. Foundayo and the Wegovy pill start around $149/month through a telehealth provider such as Ro or directly from the manufacturers via LillyDirect and NovoCare, with higher doses costing more and a membership fee possibly applying.

What should I ask my doctor?

Ask which lane fits your exact drug, dose, diagnosis, starting BMI, and insurance. For Medicare, the key question is whether your prescription should go through the Bridge or your regular Part D coverage.

Related reading on The RX Index

• ▸Medicare GLP-1 Bridge application process
• ▸What the Medicare GLP-1 Bridge really costs
• ▸Does Medicare cover Foundayo?
• ▸Wegovy pill and insurance coverage
• ▸GLP-1 providers that accept Medicaid
• ▸How to qualify for the Medicare GLP-1 Bridge
• ▸Medicare GLP-1 Bridge program — full guide
• ▸Foundayo vs. Rybelsus — full comparison
• ▸Wegovy pill vs. Foundayo pill — side-by-side